Advertisement

Topics

PARI Respiratory Equipment, Inc. Company Profile

19:23 EDT 23rd September 2017 | BioPortfolio

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.


News Articles [882 Associated News Articles listed on BioPortfolio]

PARI Unveils New Ordering Website

MIDLOTHIAN, Va., Jan. 7, 2013 /PRNewswire/ -- PARI Respiratory Equipment welcomes 2013 by launching a customer ordering website, PARIOrder.com.  "We are pleased to serve thousands of hom...

Global Respiratory Care Equipment Market Research Report Forecast 2017 to 2021 [Updated: 26042017] Prices from USD $2800

The Global Respiratory Care Equipment Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Respiratory Care Equipment industry ove...

DRE Medical Launches Latest Online Medical Equipment Catalog

New medical equipment catalog showcases premium surgical equipment options from DRE. Louisville, Ky. (PRWEB) May 11, 2017 DRE Medical — a leading provider of new and refurbished medical equipment ...

Viral and Bacterial Upper Respiratory Tract Infection in Hospital-Based Healthcare Workers

Bacterial colonization of the respiratory tract is commonly described and usually thought to be of no clinical significance. The aim of this study by MacIntyre, et al. (2017) was to examine the p...

Register now for the world's largest respiratory meeting

(European Lung Foundation) The European Respiratory Society welcomes the interest of the press in respiratory issues and is happy to provide full assistance to journalists attending the 2017 ERS Congr...

Circadiance Partners with The VGM Group

Circadiance partners with The VGM Group to offer Independent Home Medical Equipment providers Circadiance’s innovative sleep and monitoring products. Pittsburgh, PA (PRWEB) July 05, 2017 Circadianc...

Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress

SAN DIEGO, Sept. 26, 2011 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, annou...

Incidence of respiratory viral infection in infants with respiratory symptoms evaluated for late-onset sepsis

PubMed Articles [1721 Associated PubMed Articles listed on BioPortfolio]

Systematic Error in Respiratory Impedance Using Commercial Equipment Calibrated According to Manufacturer's Instructions.

Comparison of Different Mechanical Insufflator-Exsufflator Systems by Measurement of the Peak Exspiratory Flow (PEF).

Background The management of pulmonary secretion in patients with respiratory muscle weakness using mechanical insufflator-exsufflator systems (MIE) is an established treatment option. There are sig...

Extraction of respiratory signals from the electrocardiogram and photoplethysmogram: technical and physiological determinants.

Breathing rate (BR) can be estimated by extracting respiratory signals from the electrocardiogram (ECG) or photoplethysmogram (PPG). The extracted respiratory signals may be influenced by several tech...

Respiratory Protection Program Compliance in Iranian Hospitals: Application of Fuzzy Analytical Hierarchy Process.

In hospitals, health care workers (HCWs) are exposed to a wide range of respiratory hazards, which requires using respiratory protective equipment and implementing Respiratory Protection Programs (RPP...

Key factors influencing management decisions concerning safety equipment selection.

The construction industry involves many hazardous activities that may expose workers to a wide variety of health hazards. Selection of construction safety equipment is crucial in ensuring workers' saf...

Clinical Trials [1857 Associated Clinical Trials listed on BioPortfolio]

Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

This study assesses the aerosol delivery characteristics (measured by nebulization time, serum and sputum tobramycin pharmacokinetic parameters) and safety of tobramycin administered for i...

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

The study should create data for the selection of a clinically relevant primary endpoint to assess the efficacy and safety of Buparid/PARI SINUS as compared to Budes Nasal Spray in the the...

Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study

This study assesses the aerosol delivery characteristics (measured by in vivo lung deposition, nebulization time, serum tobramycin concentrations, and pharmacokinetic parameters) and safet...

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

This study will evaluate systemic and urine pharmacokinetics in spontaneously breathing healthy volunteers following a single dose of amikacin/fosfomycin, using the PARI Investigational eF...

Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" for the diagnosis of cervical pre-cancerous lesions and cervical canc...

Companies [1141 Associated Companies listed on BioPortfolio]

PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is t...

PARI Pharma

PARI Pharma focuses on the development of aerosol delivery devices and comprehensive inhalation drug development to advance aerosol therapies where drug and device can be optimized together. Based on ...

Sperian Respiratory Protection USA, LLC

With nearly 6,000 employees worldwide, Sperian Protection (formerly Bacou-Dalloz) is the world's leading manufacturer of personal protective equipment. Sperian's expertise focuses on head, body and fa...

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory ...

Dey, L.P.

Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of resp...

More Information about "PARI Respiratory Equipment, Inc." on BioPortfolio

We have published hundreds of PARI Respiratory Equipment, Inc. news stories on BioPortfolio along with dozens of PARI Respiratory Equipment, Inc. Clinical Trials and PubMed Articles about PARI Respiratory Equipment, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PARI Respiratory Equipment, Inc. Companies in our database. You can also find out about relevant PARI Respiratory Equipment, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record